CSL plunged to the lowest in almost seven years after Australia’s biggest drugmaker postponed plans to spin off its vaccines business, as falling US flu immunizations deepen concern over a slowdown in its Seqirus unit https://t.co/beNbf0JryF ...

Novo Nordisk found a new leader for its investor relations department in an equity analyst who has recommended buying shares in the drugmaker for almost 15 years https://t.co/8v8P1sB2iH ...

Denmark’s Genmab is in advanced talks to acquire Merus, a Dutch drugmaker that’s developing a treatment for cancer of the head and neck https://t.co/etZIWnnxC2 ...

Novo Nordisk said it is laying off about 11.5% of its workforce in a "transformation" of the drugmaker's business. https://t.co/pJUR4lhGVL ...

Bristol-Myers’ CEO is stepping down from his role after six years at the company, a surprise move as the drugmaker races to find its next hit https://t.co/RzMYh7aX68 ...

Adcock Ingram surged the most on record after India’s Natco Pharma said it will acquire a stake in the South African drugmaker for about $232 million https://t.co/F8zYQF78xw ...

CapVest is in talks to acquire a majority stake in Stada Arzneimittel in a deal that could value the German drugmaker at about €10 billion ($11.7 billion) including debt https://t.co/mcTNczQt0h ...

Financial Performance - Abbott Laboratories shares slumped Thursday after narrowing its full-year outlook [1] - Abbott posted better-than-expected quarterly results [1] Market Dynamics - Demand for COVID-19 tests declines [1]

Incyte shares rose Thursday after the drugmaker named Bill Meury its new CEO, effective immediately, to replace the retiring Hervé Hoppenot. https://t.co/COaakpC1HT ...

Stock Performance - Novo Nordisk's U.S-listed shares experienced a rise [1] Market Activity - An activist investor is reportedly building a stake in Novo Nordisk, the maker of Ozempic [1]